Aflibercept monotherapy effectively rescues eyes first treated with bevacizumab

This study compared the outcomes of patients who received aflibercept from the outset of treatment for DME to those who first received bevacizumab and then were switched after 12 weeks.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553